Italfarmaco Provides Givinostat Update (January 2018) Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 7 years ago You may also like 53:15 Webinar: Twice Weekly Steroids & Exercise – Study Update and Preliminary Findings (April 2022) 3 years ago Research & Clinical Trial Webinars,Webinars 59:37 Webinar: Carrier Cardiac Care (March 2022) 3 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 59:44 Webinar: Development of Imaging Biomarkers for Becker Muscular Dystrophy (March 2022) 3 years ago Research & Clinical Trial Webinars,Webinars 1:04:50 NIH Hosts Working Group to Better Understand Immune Response in Gene Therapy Trials 3 years ago Research & Clinical Trial Webinars,Webinars 48:51 Webinar: FibroGen DMD Pamrevlumab Phase 3 Clinical Studies Highlight (February 2022) 3 years ago Research & Clinical Trial Webinars,Webinars 59:31 Connect with the Experts: Pulmonary Care (October 2021) 3 years ago Care Webinars,Webinars 1:09:52 Webinar: SRP-9001 Micro-Dystrophin Gene Therapy Clinical Update (October 2021) 3 years ago Research & Clinical Trial Webinars,Webinars 1:29:24 Connect with the Experts: Cardiac Care (September 2021) 3 years ago Care Webinars,Webinars «1…56789…25»Page 7 of 25
by: Parent Project Muscular Dystrophy
